Menin inhibitors reshape AML care, boosting targeted options for KMT2A- and NPM1-mutant disease, with promising frontline ...

Acute myeloid leukemia (AML) remains one of the most difficult blood cancers to treat. Although drug combinations are often ...

Dr. Gabriel Mannis from Stanford University and Dr. Gail Roboz from Weill Cornell Medicine discussed the evolving treatment ...

Umbilical cord blood stem cell microtransplantation combined with chemotherapy significantly prolonged disease-free survival (DFS) in patients with acute myeloid leukemia (AML) and high-risk ...

A 27-year-old woman has thanked generous strangers for raising over $133,000 almost overnight so she can undergo potentially ...

Iowa families affected by pediatric cancer are urging lawmakers to pass funding for research they say is critical. “Jack was ...

Latest mipletamig data delivers 86% clinical benefit rate with no cytokine release syndrome in 28 frontline AML patients, ...

A Winter Haven family is navigating an emotional and life-changing medical journey, as two young brothers fight the same rare ...

Here, doctors share the number-one sign of leukemia in adults over 50, plus other key symptoms like night sweats, weight loss ...

Tyrosine kinase inhibitors (TKIs) lead to similar outcomes across racial and ethnic groups when used to treat acute myeloid ...